Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Yuto Kaneda, MD, Nobuhiro Kanemura, MD PhD, Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Kimihiro Yamaguchi, MD, Takuro Matsumoto, MD PhD, Yuhei Shibata, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Senji Kasahara, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2018) 132 (Supplement 1): 4210.

https://doi.org/10.1182/blood-2018-99-110055

Published: 2018

Journal Articles

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

Senji Kasahara, MD PhD, Hiroshi Nakamura, MD, Yuto Kaneda, MD, Yoshikazu Ikoma, MD, Eri Takada, MD, Kimihiro Yamaguchi, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MDPhD, Nobuhiko Nakamura, MD PhD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Hideko Goto, MD PhD, Takeshi Hara, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD

Blood (2017) 130 (Supplement 1): 1960.

https://doi.org/10.1182/blood.V130.Suppl_1.1960.1960

Published: 2017

Journal Articles

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Soranobu Ninomiya, MD PhD, Nobuhiko Nakamura, MD PhD, Junichi Kitagawa, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 3693.

https://doi.org/10.1182/blood.V128.22.3693.3693

Published: 2016

Journal Articles

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 4210.

https://doi.org/10.1182/blood.V128.22.4210.4210

Published: 2016

Journal Articles

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 1515.

https://doi.org/10.1182/blood.V126.23.1515.1515

Published: 2015

Journal Articles

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Hisashi Tsurumi, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD

Blood (2015) 126 (23): 4947.

https://doi.org/10.1182/blood.V126.23.4947.4947

Published: 2015

Journal Articles

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD PhD, Soranobu Ninomiya, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 4953.

https://doi.org/10.1182/blood.V126.23.4953.4953

Published: 2015

Journal Articles

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

Soranobu Ninomiya, Neeharika Narala, Leslie Huye, Shigeki Yagyu, Barbara Savoldo, Gianpietro Dotti, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Carlos A. Ramos

Blood (2015) 125 (25): 3905–3916.

https://doi.org/10.1182/blood-2015-01-621474

Published: 2015

Includes: Supplemental data

Journal Articles

T Cells Expressing CD19-Specific Chimeric Antigen Receptors Are Inhibited By Indoleamine 2,3-Dioxygenase in Tumors

Soranobu Ninomiya, MD PhD, Leslie E Huye, PhD, Barbara Savoldo, MD PhD, Gianpietro Dotti, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MD PhD, Cliona M Rooney, PhD, Carlos A. Ramos, MD

Blood (2014) 124 (21): 2434.

https://doi.org/10.1182/blood.V124.21.2434.2434

Published: 2014

Journal Articles

Clinical Significance of Serum Concentration of L-Kynurenine for T-Cell Lymphoma Treated with CHOP

Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Junji Nagano, MD, Takeshi Hara, MD, PhD, Kengo Ogawa, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 1598.

https://doi.org/10.1182/blood.V118.21.1598.1598

Published: 2011

Journal Articles

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Soranobu Ninomiya, MD, Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 2639.

https://doi.org/10.1182/blood.V118.21.2639.2639

Published: 2011

Journal Articles

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Hisashi Tsurumi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Kenji Fukuno, MD, Junji Nagano, MD, Kengo Ogawa, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 3541.

https://doi.org/10.1182/blood.V118.21.3541.3541

Published: 2011

Journal Articles

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Hisashi Tsurumi, MD, PhD, Takashi Ibuka, MD, Takeshi Hara, MD, PhD, Hiroshi Araki, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Humito Onogi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Tomohiro Kato, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 5075.

https://doi.org/10.1182/blood.V116.21.5075.5075

Published: 2010

Journal Articles

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

Soranobu Ninomiya, MD, Hisashi Tsurumi, MD, PhD, Takeshi Hara, MD, PhD, Masato Hoshi, Naoe Goto, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Masahito Shimizu, MD, PhD, Kuniaki Saito, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4146.

https://doi.org/10.1182/blood.V116.21.4146.4146

Published: 2010

Journal Articles

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Nobuhiko Nakamura, MD, Soranobu Ninomiya, MD, Takeshi Hara, MD, PhD, Kenji Fukuno, MD, Masato Hoshi, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Kuniaki Saito, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4379.

https://doi.org/10.1182/blood.V116.21.4379.4379

Published: 2010

Journal Articles

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

Naoe Goto, Hisashi Tsurumi, MD, PhD, Senji Kasahara, Takeshi Hara, Nobuhiro Kanemura, Takeshi Yoshikawa, Soranobu Ninomiya, Kengo Ogawa, Toshiki Yamada, MD, Michio Sawada, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 1926.

https://doi.org/10.1182/blood.V114.22.1926.1926

Published: 2009

Journal Articles

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Soranobu Ninomiya, Nobuhiro Kanemura, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Senji Kasahara, Masahito Shimizu, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 2924.

https://doi.org/10.1182/blood.V114.22.2924.2924

Published: 2009

Journal Articles

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Soranobu Ninomiya, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Junichi Kitagawa, Nobuhiro Kanemura, Senji Kasahara, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 2812.

https://doi.org/10.1182/blood.V112.11.2812.2812

Published: 2008

NARROW

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

T Cells Expressing CD19-Specific Chimeric Antigen Receptors Are Inhibited By Indoleamine 2,3-Dioxygenase in Tumors

Clinical Significance of Serum Concentration of L-Kynurenine for T-Cell Lymphoma Treated with CHOP

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only